Osteoarthritis: From Molecular Pathways to Therapeutic Advances
In this book, we have reported the most recent discoveries and updates regarding molecular pathways in osteoarthritis. In particular, the advances regarding therapeutical options, from a molecular point of view, are largely discussed.
Sábháilte in:
| Rannpháirtithe: | |
|---|---|
| Formáid: | Leictreonach Caibidil leabhair |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Ábhair: | |
| Rochtain ar líne: | DOAB: download the publication DOAB: description of the publication |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_81115 | ||
| 005 | 20220506 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220506s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-3463-3 | ||
| 020 | |a 9783036534640 | ||
| 020 | |a 9783036534633 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-3463-3 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a GP |2 bicssc | |
| 072 | 7 | |a PS |2 bicssc | |
| 100 | 1 | |a Veronese, Nicola |4 edt | |
| 700 | 1 | |a Veronese, Nicola |4 oth | |
| 245 | 1 | 0 | |a Osteoarthritis: From Molecular Pathways to Therapeutic Advances |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (306 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a In this book, we have reported the most recent discoveries and updates regarding molecular pathways in osteoarthritis. In particular, the advances regarding therapeutical options, from a molecular point of view, are largely discussed. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Biology, life sciences |2 bicssc | |
| 653 | |a osteoarthritis | ||
| 653 | |a cartilage | ||
| 653 | |a type II collagen | ||
| 653 | |a matrix metalloproteinases | ||
| 653 | |a MMP-13 | ||
| 653 | |a regulation | ||
| 653 | |a inhibitor | ||
| 653 | |a NO synthase | ||
| 653 | |a Interleukin-1β | ||
| 653 | |a chondrocytes | ||
| 653 | |a mitochondrial dysfunction | ||
| 653 | |a mesenchimal stem cells | ||
| 653 | |a chondrocytic commitment | ||
| 653 | |a autophagy | ||
| 653 | |a miRNAs | ||
| 653 | |a hydrostatic pressure | ||
| 653 | |a adipokines | ||
| 653 | |a visfatin | ||
| 653 | |a Wnt/β-catenin | ||
| 653 | |a mechanical loading | ||
| 653 | |a obesity | ||
| 653 | |a microRNA | ||
| 653 | |a oxidative stress | ||
| 653 | |a vibrational spectroscopy | ||
| 653 | |a near-infrared spectroscopy | ||
| 653 | |a infrared spectroscopy | ||
| 653 | |a Raman spectroscopy | ||
| 653 | |a early diagnosis | ||
| 653 | |a exercise | ||
| 653 | |a physical activity | ||
| 653 | |a nutraceuticals | ||
| 653 | |a dietary supplements | ||
| 653 | |a inflammation | ||
| 653 | |a aging | ||
| 653 | |a inflammaging | ||
| 653 | |a osteochondral explant culture | ||
| 653 | |a joint modelling | ||
| 653 | |a pharmacological assay | ||
| 653 | |a native tissue analysis | ||
| 653 | |a hexosamine biosynthetic pathway | ||
| 653 | |a cartilage trauma | ||
| 653 | |a post-traumatic osteoarthritis | ||
| 653 | |a O-GlcNAcylation | ||
| 653 | |a glucosamine | ||
| 653 | |a cell death | ||
| 653 | |a therapy | ||
| 653 | |a sex as a biological variable | ||
| 653 | |a whole transcriptome sequencing | ||
| 653 | |a molecules | ||
| 653 | |a TGF-β | ||
| 653 | |a SMAD2/3 signaling | ||
| 653 | |a linker modifications | ||
| 653 | |a meniscus | ||
| 653 | |a proteomics | ||
| 653 | |a MRM | ||
| 653 | |a ECM | ||
| 653 | |a celecoxib | ||
| 653 | |a glucosamine sulfate | ||
| 653 | |a chondroprotection | ||
| 653 | |a NF-κB | ||
| 653 | |a cytokines | ||
| 653 | |a chemokines | ||
| 653 | |a pathogenesis | ||
| 653 | |a biomarker | ||
| 653 | |a chondrocyte | ||
| 653 | |a IL-1β | ||
| 653 | |a IFNγ, IL-17 | ||
| 653 | |a IL-4 | ||
| 653 | |a RNA-Seq | ||
| 653 | |a hypertrophy | ||
| 653 | |a remodeling | ||
| 653 | |a angiogenesis | ||
| 653 | |a chondroitin | ||
| 653 | |a collagen | ||
| 653 | |a methylsulfonylmethane | ||
| 653 | |a vitamin C | ||
| 653 | |a vitamin D | ||
| 653 | |a hyaluronic acid | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5144 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/81115 |7 0 |z DOAB: description of the publication |